Literature DB >> 6617700

Improvement of bone scintigraphy by quantitative evaluation compared with X-ray studies and iliac crest biopsy in malignant disease.

J P Pfeifer, W Hill, U Büll, R Burkhardt, C M Kirsch.   

Abstract

Bone marrow biopsy of the iliac crest was performed on 268 patients (124 males; 144 females). Of these patients 206 had haematological systemic disorders (HSD) or carcinoma and suspected bone involvement, which was confirmed by biopsy on 66 patients. Bone biopsy was performed not longer than 3 weeks after X-ray examination and bone scintigraphy which, combined, had already raised the suspicion of skeletal involvement in 55% of the 66 patients with skeletal involvement diagnosed by biopsy. Additional quantitative evaluation of the bone scans using bone to soft tissue ratios was able to increase the overall accuracy to 67% in that group. Additional quantitative assessment of the scan yielded considerably more effective bone scintigraphy, particularly in cases with visually normal patterns. Available equipment should therefore be used in scintigraphic bone imaging on a routine basis. It was shown that the various methods of examination, i.e. X-ray, biopsy and scintigraphy with both visual and quantitative evaluation provide their own individual values for the final diagnosis. Therefore, if one of the methods shows a negative result, bone involvement is not excluded and the others should be used for confirmation.

Entities:  

Mesh:

Year:  1983        PMID: 6617700     DOI: 10.1007/bf00253542

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  19 in total

1.  Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy.

Authors:  W M Sy; A K Mittal
Journal:  Br J Radiol       Date:  1975-11       Impact factor: 3.039

2.  Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.

Authors:  T Wiegmann; L Rosenthall; M Kaye
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

3.  [X-ray and scintigraphic diagnosis of skeletal diseases compared with alkaline phosphatase activity].

Authors:  W Bessler
Journal:  Schweiz Med Wochenschr       Date:  1974-03-09

4.  [Nuclear medicine methods in the diagnosis of bone diseases].

Authors:  U Büll; K W Frey
Journal:  Internist (Berl)       Date:  1975-08       Impact factor: 0.743

5.  The effect of radiopharmaceutical incubation time on bone scan quality.

Authors:  R E Henkin; A Woodruff; W Chang; A M Green
Journal:  Radiology       Date:  1980-05       Impact factor: 11.105

6.  Tc-99m methylene diphosphonate (MDP) bone imaging: optimum normal bone scan by optimum time delay?

Authors:  U Buell
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

7.  Significance of non-specific changes of the bone marrow tissues from the bioptic viewpoint.

Authors:  R Burkhardt; K Zettl; R Bartl
Journal:  Bibl Haematol       Date:  1978

8.  A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.

Authors:  U Buell; E Kleinhans; E Zorn-Bopp; W Reuschel; W Muenzing; E A Moser; M Seiderer
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

9.  [Bone scintigraphy in renal osteopathy].

Authors:  H J Hermann; G Gahl
Journal:  Nuklearmedizin       Date:  1976-10       Impact factor: 1.379

10.  A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.

Authors:  I Fogelman; R G Bessent; D Gordon
Journal:  Eur J Nucl Med       Date:  1981-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.